Inactief instrument

Andere talen Swedish Orphan Biovitrum AB Xetra

Aandelen

B6E

SE0000872095

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Sobi Q2 2024 report: Strong delivery driven by robust portfolio performance	16/07
Swedish Orphan Biovitrum AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	16/07
Swedish Orphan Biovitrum AB Updates Earnings Guidance for the Year 2024	16/07
The Board of Directors of Sobi exercises authorisation for repurchase of shares for the purpose of securing the company's commitments under incentive programmes	15/07
Invitation: Sobi's Q2 2024 report	03/07
Sweden's Sobi Begins Rolling Application for Gout Treatment in US	02/07
Sobi Initiates Rolling Biologics License Application to FDA for SEL-212 for the Potential Treatment of Chronic Refractory Gout	02/07
Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout	02/07
Sobi Wins EU Approval for Hemophilia A Drug Altuvoct	19/06
European Commission Grants Sobi® Marketing Authorisation for Altuvoct? for Treatment of Haemophilia A	19/06
Swedish Orphan Biovitrum : European Commission grants Sobi® Marketing Authorisation for ALTUVOCT™ for treatment of haemophilia A	19/06
Swedish Orphan Biovitrum : Sobi to present new haemophilia data at ISTH 2024	17/06
Swedish Orphan Biovitrum : Sobi to present new data across its haematology portfolio at the 2024 EHA congress	10/06
BerGenBio ASA Enter into A Clinical Trial Agreement with the Mays Cancer Center At the University of Texas Health Science Center At San Antonio and Swedish Orphan Biovitrum AB	28/05
Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting	24/05
Sobi North America Gets FDA Fast Track Designation for Rheumatic Disease Complication Treatment	24/05
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome	24/05
Bulletin from Sobi's Annual General Meeting (AGM)	14/05
Swedish Orphan Biovitrum AB Elects Zlatko Rihter as New Board Member	14/05
Sobi Finalizes Inaugural SEK3 Billion Bond Issue	08/05

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Swedish Orphan Biovitrum AB Xetra

Aandelen

B6E

SE0000872095

Andere talen

Filters